-The Hindu New Delhi should stop its flip-flops and adopt a coherent policy in its negotiations on greenhouse gas emissions If the great Scott Fitzgerald were to have walked into the grand plenary hall of the Durban climate conference in 2011 to announce once again, "show me a hero and I will write you a tragedy," all fingers would have pointed to the tiny Indian contingent in the room. There, Fitzgerald would...

-The Times of India A patch of wheat found growing in fallow field in Oregon, USA, has sent tremors across the world with some East Asian countries cancelling wheat import orders from the US, and the 27 member European Union to raise testing levels for US imports. The reason is that the wheat patch was found to be a genetically modified variety developed and tested by biotech giant Monsanto between 1999 and...

-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...

-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...

-The Hindu The Commerce and Industry Ministry, on Thursday, issued new guidelines for pharmaceutical makers to comply with the European Union (EU) Good Manufacturing Practice (GMP) standards. In a statement issued here, the Ministry says such a move will give a boost to pharma Exports from India. "India has demonstrated its keenness to meet international requirements for Exports of pharmaceutical products yet again by taking timely action for complying with the new...